Lung cancer, Small cell lung cancer
Results
Phase 1
This trial looked at carboplatin, with different doses of irinotecan, for people with extensive small cell lung cancer.
Doctors usually treat small cell lung cancer with 2 chemotherapy drugs called etoposide and either cisplatin or carboplatin. Lung cancer often responds well to these drugs, but unfortunately it usually comes back later.
We know from research that irinotecan may also help people with small cell lung cancer. Doctors thought the combination of irinotecan and carboplatin might have been a better treatment for small cell lung cancer.
The aims of this trial were to find out
The best dose of irinotecan to give with carboplatin
What the side effects of this drug combination were
How well this treatment worked
Recruitment start: 1 September 2004
Recruitment end: 21 September 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Christian Ottensmeier
Experimental Cancer Medicine Centre (ECMC)
University Hospital Southampton NHS Foundation Trust
University of Southampton
Last reviewed: 13 Jan 2016
CRUK internal database number: 670